ImmuneBridge has filed a notice of an exempt offering of securities to raise $12,000,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, ImmuneBridge is raising $12,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Peretz Partensky played a key role in…